Chemiluminescent Immunoassays (CLIAs) have revolutionized biological and chemical detection. Based on the detection of a protein that glows or emits light in a chemiluminescent reaction, CLIA is a faster assays technique that does not require stop reactions and has short incubation times. In addition, it has a much wider detection range than either RIAs or ELISAs and is also extremely sensitive under low analyte concentration conditions.
CDSimple™ Chemiluminescent ELISA platform offers a seamless process through which we will develop high-quality assays for your application. Depending on your need, assays may be developed for basic research purposes or designed to include additional qualification and validation.
Creative Diagnostics will carry out the approval proposal and deliver the expected results and documents in a time and cost effective manner. Our staff scientists follow rigorous guidelines for quality control with a focus on thorough optimization and validation of every aspect of assay development, including antibody specificity, assay sensitivity, reproducibility (intra- and inter-assay), cross-reactivity, standard curve range, assay accuracy (linearity and recovery) and kit stability.